N. Bernard

1.1k total citations
42 papers, 644 citations indexed

About

N. Bernard is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, N. Bernard has authored 42 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 13 papers in Epidemiology and 10 papers in Virology. Recurrent topics in N. Bernard's work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). N. Bernard is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (10 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). N. Bernard collaborates with scholars based in France, Belize and French Guiana. N. Bernard's co-authors include Fabrice Bonnet, J Beylot, M. Dupon, François Dabis, P. Mercié, D. Lacoste, Marianne Savès, Catherine Marimoutou, M. Bonarek and Philippe Morlat and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and AIDS.

In The Last Decade

N. Bernard

37 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Bernard France 13 305 263 236 170 134 42 644
Dariela Micheloud Spain 18 247 0.8× 335 1.3× 188 0.8× 172 1.0× 143 1.1× 48 780
Paola Cicconi Italy 17 489 1.6× 351 1.3× 130 0.6× 369 2.2× 301 2.2× 45 881
Beverly Alston‐Smith United States 13 421 1.4× 329 1.3× 187 0.8× 281 1.7× 610 4.6× 23 1.0k
J. Medraño Spain 20 448 1.5× 705 2.7× 690 2.9× 173 1.0× 222 1.7× 43 1.2k
Henning Drechsler United States 14 614 2.0× 267 1.0× 114 0.5× 382 2.2× 532 4.0× 25 1.0k
Elina Teicher France 19 459 1.5× 458 1.7× 527 2.2× 168 1.0× 268 2.0× 41 1.1k
Όλγα Κατσαρού Greece 17 179 0.6× 115 0.4× 57 0.2× 156 0.9× 74 0.6× 45 782
F. Raffi France 6 316 1.0× 161 0.6× 71 0.3× 139 0.8× 304 2.3× 16 530
David Verhelst France 8 203 0.7× 113 0.4× 54 0.2× 81 0.5× 117 0.9× 15 522
Tania Mudrikova Netherlands 12 242 0.8× 248 0.9× 123 0.5× 104 0.6× 64 0.5× 39 456

Countries citing papers authored by N. Bernard

Since Specialization
Citations

This map shows the geographic impact of N. Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Bernard more than expected).

Fields of papers citing papers by N. Bernard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Bernard. The network helps show where N. Bernard may publish in the future.

Co-authorship network of co-authors of N. Bernard

This figure shows the co-authorship network connecting the top 25 collaborators of N. Bernard. A scholar is included among the top collaborators of N. Bernard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Bernard. N. Bernard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rullier, Anne, Samuel Amintas, Brigitte Le Bail, et al.. (2025). Recycled formalin: a new tool to mitigate the environmental impact of surgical pathology in routine practice. Pathology. 57(4). 437–442.
2.
Nguyen, Yann, Adrien Michon, Bertrand Lioger, et al.. (2024). Création du club Greenternist : la médecine interne en transition écologique. La Revue de Médecine Interne. 45(7). 397–399. 2 indexed citations
5.
Bernard, N., et al.. (2015). Rapport sur l’utilisation des inhibiteurs de la pompe à protons : les recommandations françaises sont-elles respectées ?. La Revue de Médecine Interne. 36(10). 651–657. 7 indexed citations
6.
Vandenhende, M.A., Fabrice Bonnet, D. Lacoste, et al.. (2013). Adéquation entre les prescriptions antibiotiques et les recommandations dans un service de médecine interne : une démarche d’évaluation des pratiques professionnelles. La Revue de Médecine Interne. 34(8). 456–459. 2 indexed citations
7.
Dousset, Vincent, N. Bernard, Jean-Philippe Maire, et al.. (2008). Prise en charge de la douleur dans les services de médecine au CHU de Bordeaux.
8.
Morlat, Philippe, et al.. (2006). Association hépatite auto-immune et hépatite virale C : cinq nouvelles observations. La Revue de Médecine Interne. 27(12). 916–923. 1 indexed citations
9.
Bonnet, Fabrice, M. Bonarek, Philippe Morlat, et al.. (2003). Risk Factors for Lactic Acidosis in HIV‐Infected Patients Treated with Nucleoside Reverse‐Transcriptase Inhibitors: A Case‐Control Study. Clinical Infectious Diseases. 36(10). 1324–1328. 45 indexed citations
10.
Legrand, Elisabeth, D. Neau, Tatiana Galpérine, et al.. (2002). CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment. The Journal of Infectious Diseases. 186(3). 302–311. 9 indexed citations
11.
Bonnet, Fabrice, S. Lawson‐Ayayi, Rodolphe Thiébaut, et al.. (2002). A Cohort Study of Nevirapine Tolerance in Clinical Practice: French Aquitaine Cohort, 1997–1999. Clinical Infectious Diseases. 35(10). 1231–1237. 41 indexed citations
12.
Bonnet, Fabrice, Philippe Morlat, X. Delbrel, et al.. (2001). Sarcoïdose et comorbidité : étude rétrospective de 32 observations. La Revue de Médecine Interne. 22(7). 619–623. 13 indexed citations
13.
Savès, Marianne, Philippe Morlat, Geneviève Chêne, et al.. (2001). Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy. Clinical Immunology. 99(3). 347–352. 25 indexed citations
14.
Delèvaux, I., N. Bernard, P. Morlat, et al.. (2000). Plasmocytomes multiples médullaires et extramédullaires chez une patiente infectée par le VIH. La Revue de Médecine Interne. 21(7). 623–627. 2 indexed citations
15.
Bonnet, Fabrice, Philippe Morlat, I. Delèvaux, et al.. (2000). A possible association between Chlamydiae psittacci infection and temporal arteritis. Joint Bone Spine. 67(6). 550–552. 3 indexed citations
16.
Savès, Marianne, Stéphanie Vandentorren, V. Daucourt, et al.. (1999). Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-1998. AIDS. 13(17). 115–151. 121 indexed citations
17.
Bernard, N., et al.. (1998). Predictive Factors of Occurrence of Cytomegalovirus Disease and Impact on Survival in the Aquitaine Cohort in France, 1985 to 1994. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(2). 171–178. 16 indexed citations
18.
Bernard, N., Philippe Morlat, Yannick Blanchard, et al.. (1997). Incidence of cytomegalovirus disease in the aquitaine cohort of HIV-infected patients: A retrospective survey, 1987–1993. Journal of Infection. 35(2). 155–161. 4 indexed citations
19.
Morlat, Philippe, D. Lacoste, N. Bernard, et al.. (1996). La pneumocystose pulmonaire au cours du sida: analyse rétrospective de 80 cas documentés (1985–1993). La Revue de Médecine Interne. 17(1). 25–33. 2 indexed citations
20.
Pellegrin, Isabelle, Elisabeth Legrand, D. Neau, et al.. (1996). Kinetics of Appearance of Neutralizing Antibodies in 12 Patients with Primary or Recent HIV-1 Infection and Relationship with Plasma and Cellular Viral Loads. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 11(5). 438–447. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026